Intelligence Platform

Patents

Browse 132 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

patent

US 8614183

Use of FGFR1 extra cellular domain proteins to treat cancers characterized by ligand-depen

Five Prime Therapeutics, Inc. · Granted Tue Dec 24 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 19 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8580936

Polynucleotides encoding FGFR1-IIIc ECD fusion proteins

Five Prime Therapeutics, Inc. · Granted Tue Nov 12 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8575312

Compositions and methods of use for MGD-CSF in disease treatment

Five Prime Therapeutics, Inc. · Granted Tue Nov 05 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 31 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8501191

FGFR2-IIIb fusion proteins and methods of making them

Five Prime Therapeutics, Inc. · Granted Tue Aug 06 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 01 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8481010

Covalently bonding nail primer

Creative Nail Design Inc. · Granted Tue Jul 09 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 04 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8481038

Treatment of cancer with elevated dosages of soluble FGFR1 fusion proteins

Five Prime Therapeutics, Inc. · Granted Tue Jul 09 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 04 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8470789

Method for inducing and accelerating cells

DCPRIME B.V. · Granted Tue Jun 25 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 20 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8445445

Method of promoting hair growth using FGFR4 extracellular domains

Five Prime Therapeutics, Inc. · Granted Tue May 21 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 16 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8440202

Induction of an immune response against dengue virus using the prime-boost approach

United States of America as represented by the Secretary of the Air Force · Granted Tue May 14 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 09 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8431532

FZD8 extracellular domains and FZD8 extracellular domain fusion molecules and treatments u

Five Prime Therapeutics, Inc. · Granted Tue Apr 30 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 25 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8404810

Compositions and methods of use for modulators of polypeptides and polynucleotides in trea

Five Prime Therapeutics, Inc. · Granted Tue Mar 26 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8394380

Compositions and methods for alzheimer's disease

Primex Clinical Laboratories, Inc. · Granted Tue Mar 12 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8338569

FGFR extracellular domain acidic region muteins

Five Prime Therapeutics, Inc. · Granted Tue Dec 25 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8324165

Compositions for treating arthritis comprising HG1023575 polypeptide

Five Prime Therapeutics, Inc. · Granted Tue Dec 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8263759

Sets of probes and primers for the diagnosis of select cancers

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Sep 11 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8241638

Induction of an immune response against dengue virus using the prime-boost approach

United States of America as represented by the Secretary of the Air Force · Granted Tue Aug 14 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 09 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8206715

Antibodies that bind colony stimulating factor 1 receptor (CSF1R)

Five Prime Therapeutics, Inc. · Granted Tue Jun 26 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 21 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8183207

Treatment of osteolytic disorders and cancer using CSF1R extracellular domain fusion molec

Five Prime Therapeutics, Inc. · Granted Tue May 22 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 17 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8178109

Compositions and methods of use for MGD-CSF in disease treatment

Five Prime Therapeutics, Inc. · Granted Tue May 15 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 10 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8173134

ECD carboxy-terminal deletion FGFR4 fusion proteins and methods of producing them

Five Prime Therapeutics, Inc. · Granted Tue May 08 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 03 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8168588

Compositions comprising FGF-9 and betacellulin and methods for treating cardiac conditions

Five Prime Therapeutics, Inc. · Granted Tue May 01 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8168751

Interferon alpha mutant and its polyethylene glycol derivative

Beijing Tri-Prime Genetic Engineering Co., Ltd · Granted Tue May 01 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8119398

Adipose-derived stem cells for tissue regeneration and wound healing

PrimeGen Biotech LLC · Granted Tue Feb 21 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8080246

Colony stimulating factor 1 receptor (CSF1R) extracellular domain fusion molecules

Five Prime Therapeutics, Inc. · Granted Tue Dec 20 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 15 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted